Jean-Frederic Colombel, MD
img_Jean-Frederic Colombel
PROFESSOR | Medicine, Gastroenterology
PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Gastroenterology

MD, Universite Picardie

Fellowship, Transplant Hepatology, Hospital Center University De Lille

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Natural History of Anal Strictures in Pediatric-Onset Crohn’s Disease: Long-term Follow-up of a Population-Based Study. Perrine Mortreux, Ariane Leroyer, Delphine Ley, Claire E. Dupont-Lucas, Valérie Bertrand, Nathalie Guillon, Pauline Wils, Hugues B. Coevoet, Thierry Paupard, Corinne Gower-Rousseau, Laurent Siproudhis, Nicolas Richard, Dominique D. Turck, Guillaume Savoye, Hélène Sarter, Mathurin Fumery, R. Al Hameedi, M. Al Khatib, S. Al Turk, E. Agoute, J. M. Andre, M. Antonietti, A. Aouakli, A. Armand, L. Armengol-Debeir, I. Aroichane, F. Assi, J. P. Aubet, E. Auxenfants, A. Avram, F. Ayafi-Ramelot, K. Azzouzi, D. Bankovski, B. Barbry, N. Bardoux, P. Baron, A. Baudet, P. Bayart, B. Bazin, A. Bebahani, J. P. Becqwort, S. Bellati, V. Benet, H. Benali, C. Benard, C. Benguigui, E. Ben Soussan, A. Bental, I. Berkelmans, J. F. Colombel. Diseases of the Colon and Rectum

A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn’s disease: the TEOREM trial. Franck Carbonnel, Nicolas Barnich, Patricia Lepage, Xavier Hébuterne, Christophe Michiels, Cyrielle Gilletta, Pauline Wils, David Laharie, Romain Altwegg, Mathieu Allez, Yoram Bouhnik, Antoine Meyer, Clémence Breton, Hélène Agostini, Domitille Molinari, Ryan Balfour Sartor, Jean Yves Mary, Jean Frédéric Colombel, Caroline Chevarin, Frédéric Faure, Anouk Walter-Petrich, Sylvie Chevret, Anthony Buisson. Journal of Crohn's and Colitis

A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis. Silvio Danese, Michael E. Rothenberg, Jeremy J. Lim, Han Ting Ding, Jacqueline M. McBride, Yiling Chen, Ajit Dash, Jordan S. Mar, Mary Keir, Laurent Peyrin-Biroulet, Julian Panes, Jean Frederic Colombel, Brian Feagan, John F. Valentine, Stefan Schreiber. Clinical Gastroenterology and Hepatology

View All Publications

Looking Back and in the Distance: Are We on Track to Change IBD Patients' Lives

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Colombel during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Protagonist Therapeutics, Inc.
  • Envision Pharma
  • Immunic
  • GlaxoSmithKline
  • Pfizer Inc.
  • Shire
  • Ferring Pharmaceuticals
  • Boehringer Ingelheim Corporation
  • Anapty Bio
  • Boxer
  • Eli Lilly and Company
  • Ensho
  • Merck & Co., Inc.
  • Microbia Novartic
  • Landos
  • Alimentiv
  • Tigenix
  • Celgene Corporation
  • Teva
  • Amgen Inc.
  • Sanofi
  • Takeda Pharmaceuticals International GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • Bristol-Myers Squibb
  • WEBMD Health Corp
  • Integritas Communication
  • Prometheus Laboratories Inc.
  • AbbVie Inc.
  • Sun
  • Arena
  • Imedex, LLC.
  • Seres
  • Allergan, Inc.
  • Genentech, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Union Therapeutics A/S
  • Iterative Scope
  • Vifor
  • Galmed research
  • Guide Point
  • Kaleido

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Intestinal Biotech Development

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.